FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.
FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.
In February 2013, San Diego-based Synteract acquired Munich-based Harrison Clinical Research – and expanded our services and strength to the Power of Two – two excellent CROs that, together as one, deliver international, full-service clinical trial services.
Now operating under our new name, SynteractHCR is a dedicated contract research organization with a successful track record of more than two decades supporting pharmaceutical, biotechnology and medical device companies in all phases of clinical development, across multiple therapeutic areas. We work closely with you to customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.
SynteractHCR operates in 16 countries offering our clients strong international and regional clinical trial support throughout the world. Our geographic footprint extends from North America to Europe, Israel and has an emerging presence in South America.
We collaborate with every client to offer you a tailored approach to fit your project needs. We know every project matter and each is unique. You can outsource an entire project or only as much help as you need. We work with you on your drug development goals to ensure every aspect is planned for and done right, while driving efficiencies and cost-effectiveness.
The services SynteractHCR offer, include:
We have managed over 3500 projects across all phases of clinical development, and have contributed to numerous product approvals. During our history, we have addressed the most demanding drug development challenges.
Our mission is to support the innovation and development of better therapies in healthcare. Our focus on patients’ safety and comfort helps us to establish ethical standards for everything we do.